Insmed to Present at the Deutsche Bank 43rd Annual Health Care Conference
02 Mai 2018 - 3:21PM
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical
company focused on the unmet needs of patients with rare diseases,
today announced that Will Lewis, President and Chief Executive
Officer of Insmed, will present at the Deutsche Bank 43rd Annual
Health Care Conference in Boston, MA on Tuesday, May
8, 2018 at 4:10 p.m. EDT.
The presentation will be webcast live and can be accessed by
visiting the investor relations section of the company's website at
www.insmed.com. The webcast will be archived for a period of 90
days following the conclusion of the live event.
About Insmed
Insmed Incorporated is a global biopharmaceutical Company
focused on the unmet needs of patients with rare diseases. The
Company’s lead product candidate is ALIS, which is in late-state
development for adult patients with treatment refractory NTM lung
disease caused by MAC, which is a rare and often chronic infection
that is capable of causing irreversible lung damage and can be
fatal. Insmed's earlier-stage clinical pipeline includes
INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase
1 with therapeutic potential in non-cystic fibrosis bronchiectasis
and other inflammatory diseases, and INS1009, an inhaled
nanoparticle formulation of a treprostinil prodrug that may offer a
differentiated product profile for rare pulmonary disorders,
including pulmonary arterial hypertension. For more
information, visit www.insmed.com.
Contact:
Blaine Davis Insmed Incorporated (908) 947-2841
blaine.davis@insmed.com
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024